Marshall Wace Asia’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Marshall Wace Asia’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$492K	Buy	+23,451	New	+$458K	0.2%	13

Other funds holding WX

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CI Investments Inc Toronto, Ontario, Canada $31.2B AUM 40.61% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Marshall Wace Asia's WX Position: Q2 2013 in Review

Marshall Wace Asia opened a new position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2013: 23,451 shares worth $492K. The stake represents 0.2% of the portfolio and ranks #13 among its holdings.

113 funds tracked by Wall St. Rank hold WX as of Q2 2013.

Marshall Wace Asia held 23,451 shares of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS worth $492K as of Q2 2013.
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS was a new Marshall Wace Asia position in Q2 2013.
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS made up 0.2% of Marshall Wace Asia's portfolio in Q2 2013, its #13 holding.
113 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2013.

Based on Marshall Wace Asia's 13F filing for Q2 2013, filed 6 Aug 2013.